American International Group’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-11,491
| Closed | -$388K | – | 195 |
|
2024
Q1 | $388K | Sell |
11,491
-99
| -0.9% | -$3.34K | ﹤0.01% | 1779 |
|
2023
Q4 | $365K | Sell |
11,590
-47
| -0.4% | -$1.48K | ﹤0.01% | 1834 |
|
2023
Q3 | $297K | Buy |
11,637
+414
| +4% | +$10.6K | ﹤0.01% | 1895 |
|
2023
Q2 | $322K | Buy |
11,223
+69
| +0.6% | +$1.98K | ﹤0.01% | 1910 |
|
2023
Q1 | $267K | Buy |
11,154
+221
| +2% | +$5.3K | ﹤0.01% | 1953 |
|
2022
Q4 | $185K | Sell |
10,933
-40
| -0.4% | -$678 | ﹤0.01% | 2167 |
|
2022
Q3 | $163K | Buy |
10,973
+156
| +1% | +$2.32K | ﹤0.01% | 2273 |
|
2022
Q2 | $170K | Buy |
10,817
+336
| +3% | +$5.28K | ﹤0.01% | 2295 |
|
2022
Q1 | $283K | Sell |
10,481
-738
| -7% | -$19.9K | ﹤0.01% | 2036 |
|
2021
Q4 | $415K | Sell |
11,219
-335
| -3% | -$12.4K | ﹤0.01% | 1937 |
|
2021
Q3 | $552K | Sell |
11,554
-275
| -2% | -$13.1K | ﹤0.01% | 1785 |
|
2021
Q2 | $400 | Buy |
11,829
+92
| +0.8% | +$3 | ﹤0.01% | 2072 |
|
2021
Q1 | $485 | Sell |
11,737
-1,058
| -8% | -$44 | ﹤0.01% | 1856 |
|
2020
Q4 | $555 | Buy |
12,795
+3,226
| +34% | +$140 | ﹤0.01% | 1692 |
|
2020
Q3 | $411K | Buy |
9,569
+1,594
| +20% | +$68.5K | ﹤0.01% | 1690 |
|
2020
Q2 | $373K | Buy |
+7,975
| New | +$373K | ﹤0.01% | 1749 |
|
2015
Q3 | – | Sell |
-21
| Closed | -$981 | – | 4965 |
|
2015
Q2 | $981 | Hold |
21
| – | – | ﹤0.01% | 4974 |
|
2015
Q1 | $845 | Hold |
21
| – | – | ﹤0.01% | 4924 |
|
2014
Q4 | $560 | Buy |
+21
| New | +$560 | ﹤0.01% | 4907 |
|